BAY 593, identified by the CAS number 2413020-57-0, is a chemical compound that has garnered attention in the field of medicinal chemistry and pharmacology. While specific details about its characteristics may vary, compounds like BAY 593 are typically evaluated for their biological activity, solubility, stability, and potential therapeutic applications. Such substances are often studied for their interactions with biological targets, which can include enzymes or receptors, and may exhibit properties such as selectivity and potency. Additionally, the compound's physical characteristics, such as molecular weight, melting point, and spectral data (like NMR or mass spectrometry), are crucial for understanding its behavior in various environments. Safety and toxicity profiles are also essential considerations in the development and application of such compounds. Overall, BAY 593 represents a class of compounds that are under investigation for their potential use in treating specific medical conditions, although detailed information about its specific characteristics would require access to specialized databases or scientific literature.

BAY 593                                    New

2413020-57-0: BAY 593, identified by the CAS number 2413020-57-0, is a chemical compound that has garnered attention in the field of medicinal chemistry and pharmacology. While specific details about its characteristics may vary, compounds like BAY 593 are typically evaluated for their biological activity, solubility, stability, and potential therapeutic applications. Such substances are often studied for their interactions with biological targets, which can include enzymes or receptors, and may exhibit properties such as selectivity and potency. Additionally, the compound's physical characteristics, such as molecular weight, melting point, and spectral data (like NMR or mass spectrometry), are crucial for understanding its behavior in various environments. Safety and toxicity profiles are also essential considerations in the development and application of such compounds. Overall, BAY 593 represents a class of compounds that are under investigation for their potential use in treating specific medical conditions, although detailed information about its specific characteristics would require access to specialized databases or scientific literature.

BAY 593 functions as an inhibitor of geranylgeranyltransferase-I (GGTase-I), effectively preventing the activation of Rho-GTPases and consequently inactivating YAP1/TAZ signaling pathways. It has been shown to inhibit tumor growth dose-dependently in xenograft mouse models, exhibiting IC50 values of 38.4 nM in MT-1080 cells and 564 nM in MDA-MB-231 cells, as well as in PXF 541 xenografts.

CAS 2413020-57-0

BAY 593 New

BAY 593

Ref: TM-T201377